Zacks Small Cap Research on MSN
BLRX: A Venture into GBM
BLRX READ THE FULL BLRX RESEARCH REPORT In a highly anticipated event, BioLineRx Ltd. (NASDAQ:BLRX) announced a deal to develop a new cancer drug in a joint venture with Hemispherian AS. Hemispherian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback